Stockholders' Deficit (Detail) - USD ($) $ in Thousands		3 Months Ended
		Mar. 24, 2024	Mar. 26, 2023
Stockholders' Deficit [Line Items]
Balance	[1]	$ (4,070,367)
Net Income (Loss)		125,824	$ 104,770
Balance		$ (4,008,330)
Common Stock [Member]
Stockholders' Deficit [Line Items]
Balance (in shares)		34,726,182	35,419,718
Balance		$ 347	$ 354
Issuance and cancellation of stock awards, net (in shares)		44,053	14,495
Issuance and cancellation of stock awards, net		$ 1
Tax payments for restricted stock upon vesting, (in shares)		(15,213)	(5,073)
Purchases of common stock, (in shares)		(56,372)	(100,515)
Purchases of common stock		$ (1)	$ (1)
Exercises of stock options, (in shares)		103,107	1,508
Exercises of stock options		$ 1
Balance (in shares)		34,801,757	35,330,133
Balance		$ 348	$ 353
Additional Paid-in Capital [Member]
Stockholders' Deficit [Line Items]
Balance		2,801	9,693
Tax payments for restricted stock upon vesting		(6,700)	(1,553)
Purchases of common stock		(17,021)	(14,547)
Exercises of stock options		10,773	343
Non-cash equity-based compensation expense		11,338	7,538
Balance		1,191	1,474
Retained Deficit [Member]
Stockholders' Deficit [Line Items]
Balance		(4,069,648)	(4,194,418)
Net Income (Loss)		125,824	104,770
Dividends declared on common stock and equivalents		(52,954)	(43,005)
Purchases of common stock		(8,099)	(15,802)
Balance		(4,004,877)	(4,148,455)
Accumulated Other Comprehensive Loss [Member]
Stockholders' Deficit [Line Items]
Balance		(3,867)	(4,694)
Currency translation adjustment		(1,125)	(451)
Balance		$ (4,992)	$ (5,145)

[1] The condensed consolidated balance sheet at December 31, 2023 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.